Clinical Trial Update: DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study comparing DFD06 Cream to clobetasol propionate 0.05% in moderate-to-severe plaque psoriasis to evaluate HPA axis suppression; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Clobetasol Propionate Cream 0.05% (clobetasol propionate)
• DFD06 Cream

Snippet

Sponsor: Promius Pharma, LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-04-18